(Q38409089)

2 September 2017

title

Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients (English)

1 reference

2 September 2017

1 reference

1 reference

Xiangyu Che

1

1 reference

2 September 2017

Deyong Yang

2

1 reference

2 September 2017

Huafeng Zong

3

1 reference

2 September 2017

Jianbo Wang

4

1 reference

2 September 2017

Xiancheng Li

5

1 reference

2 September 2017

Feng Chen

6

1 reference

2 September 2017

Xiaochi Chen

7

1 reference

2 September 2017

Xishuang Song

8

1 reference

2 September 2017

publication date

27 July 2011

1 reference

2 September 2017

1 reference

2 September 2017

volume

30

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

450-456

1 reference

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Intravesical therapy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

IAP-targeted therapies for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

New approaches and therapeutics targeting apoptosis in disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Mammalian mitochondrial IAP binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Toxic proteins released from mitochondria in cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

IAPs: more than just inhibitors of apoptosis proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

The inhibitor of apoptosis proteins as therapeutic targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Evaluation of the Prognostic Value of Cellular Inhibitor of Apoptosis Protein in Epithelial Ovarian Cancer Using Automated Quantitative Protein Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

xIAP induces cell-cycle arrest and activates nuclear factor-kappaB : new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Livin-α promotes cell proliferation by regulating G1-S cell cycle transition in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

A survivin-ran complex regulates spindle formation in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

Asymmetric recruitment of cIAPs by TRAF2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.12.016

10.1016/J.UROLONC.2010.12.016

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference